Merck opposes plan to try cases of long term Vioxx users
We had reported earlier that Judge Carol Higbee had proposed that some of the next Vioxx lawsuits to go on trial should be those that involved long term users has met with strong opposition from Merck. Apparently the company thinks that if it has to face only those cases that it is bound to lose, it will not be good for the company.
The company was delighted with the outcome of the Mike Humeston case in which it one because he had taken the drug for just two months. Having several outcomes of this type will not only help the company argue that it has a strong chance in Vioxx litigation, it may also allow it to negotiate better terms with victims when it eventually settles the lawsuits.
Related article: Should you settle your Vioxx lawsuit?